Skip to main content
Clinical Trials/NCT02924168
NCT02924168
Completed
Not Applicable

Effect of Radial Shock Waves for the Treatment of Upper Limb Functional Disability in Stroke Sequelae

Marta Imamura1 site in 1 country22 target enrollmentSeptember 2013
ConditionsIschemic Stroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ischemic Stroke
Sponsor
Marta Imamura
Enrollment
22
Locations
1
Primary Endpoint
Fugl-Meyer Assessment (FMA)
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This is a double blind randomized clinical trial to evaluate the effect of radial shock waves on functional recovery of the upper limb of patients with sequelae of ischemic strokes in the territory of the middle cerebral artery. A total of 20 patients will be enrolled and will undergo motor, functional and cortical excitability evaluations before and after four weekly sessions of radial shockwaves. 5,000 pulses with a frequency of 15 Hz and 3.5 to 4 bar of air pressure will be applied to the active group, resulting in an energy flux density (EFD) of approximately 0.07 mJ/mm2. The sham group will receive identical treatment, except for the fact that no energy flux will be applied.

Registry
clinicaltrials.gov
Start Date
September 2013
End Date
February 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Marta Imamura
Responsible Party
Sponsor Investigator
Principal Investigator

Marta Imamura

MD PhD

University of Sao Paulo

Eligibility Criteria

Inclusion Criteria

  • Clinical and radiological diagnosis: Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) scan indicating Stroke in the territory of the middle cerebral artery;
  • 6 to 24 months after stroke date;
  • Stability observed in clinical medical evaluation
  • Granting of written informed consent to participate in the study

Exclusion Criteria

  • Individuals with a score lower than 24 on the Mini-mental test;
  • Previously documented strokes
  • Pregnancy
  • Patients treated with botulinum toxin, phenol, alcohol or previous surgeries six months before entering the study
  • Bone diseases, pre-existing joint damage, and deformities affecting the patient in a way to interfere with implementation of the proposed therapy
  • Psycho-affective disorder that prevents adherence
  • Joint pain that occurs within the movement range of therapies

Outcomes

Primary Outcomes

Fugl-Meyer Assessment (FMA)

Time Frame: Change from baseline to 8 weeks

Mean change in Fugl Meyer Assessment score after four sessions of Radial Shockwave Therapy (RSWT) as compared to baseline.

Secondary Outcomes

  • Jebsen-Taylor Hand Function Test (JTHFT)(Baseline, one and two months)
  • Change in fine motor function measured with Finger Tapping (FT)(Baseline, one and two months)
  • Purdue Pegboard Test (PPBT)(Baseline, one and two months)
  • Medical Research Council scale (MRC)(Baseline, one and two months)
  • Robotic kinematic evaluation (RKE)(Baseline, one and two months)
  • Pinch strength testing(Baseline, one and two months)
  • Visual Analogue Scale (VAS)(Baseline, one and two months)
  • Esthesiometry - Von Frey Scale(Baseline, one and two months)
  • Fugl-Meyer Assessment(Baseline and two months)
  • Hand grip(Baseline, one and two months)
  • Corticospinal excitability measures with transcranial magnetic stimulation (TMS)(Baseline, one and two months)
  • Upper Limb Modified Ashworth Scale (MAS)(Baseline, one week, two weeks, three weeks, four weeks and two months)

Study Sites (1)

Loading locations...

Similar Trials